Role of calcitonin gene-related peptide and substance P in different models of pain

Cephalalgia

Volumn 28, Issue 2, 2008, Pages 114-126

  Greco, R ^a   Tassorelli, C ^a   Sandrini, G ^a   Di Bella, P ^b   Buscone, S ^a   Nappi, G ^a,c  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

CGRP; Formalin test; NTG; SP

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; FORMALDEHYDE; GLYCERYL TRINITRATE; SUBSTANCE P;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUMBAR SPINAL CORD; MALE; NONHUMAN; PAIN; RAT; SPINAL CORD DORSAL HORN; TRIGEMINAL NUCLEUS;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CENTRAL NERVOUS SYSTEM; FORMALDEHYDE; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SUBCUTANEOUS; LUMBOSACRAL REGION; MALE; NITROGLYCERIN; PAIN; POSTERIOR HORN CELLS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; TRIGEMINAL CAUDAL NUCLEUS;

EID: 38049156085     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1111/j.1468-2982.2007.01468.x     Document Type: Article

References (68)

1. McMahon SB, Lewin GR, Wall PD. Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993 3 : 602 10.
2. Meller ST, Gebhart GF. Spinal mediators of hyperalgesia. Drugs 1994 47 : 10 12.
3. Meller ST, Gebhart GF. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993 52 : 127 36.
4. Garry MG, Richardson JD, Hargreaves KM. Sodium nitroprusside evokes the release of immunoreactive calcitonin gene-related peptide and substance P from dorsal horn slices via nitric oxide-dependent and nitric oxide-independent mechanisms. J Neurosci 1994 14 : 4329 37.
5. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 2004 24 : 611 22.
6. Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002 346 : 257 70.
7. Fusayasu E, Kowa H, Takeshima T, Nakaso K, Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 2007 128 : 209 14.
8. Uddman R, Edvinsson L, Ekblad E, Hakanson R, Sundler F. Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatatory effects. Regul Pept 1986 15 : 1 23.
9. Brain SD. Calcitonin gene-related peptide (CGRP) antagonists: blockers of neuronal transmission in migraine. Br J Pharmacol 2004 142 : 1053 4.
10. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiederberg's Arch Pharmacol 1979 310 : 173 208.
11. Sances G, Tassorelli C, Pucci E, Ghiotto N, Sandrini G, Nappi G. Reliability of the nitroglycerin provocative test in the diagnosis of neurovascular headaches. Cephalalgia 2004 24 : 110 19.
12. Tvedskov JF, Thomsen LL, Iversen HK, Williams P, Gibson A, Jenkins K et al. The effect of propranolol on glyceryltrinitrate-induced headache and arterial response. Cephalalgia 2004 24 : 1076 87.
13. Tassorelli C, Greco R, Dechun W, Sandrini M, Sandrini G, Nappi G. Nitroglycerin induces hyperalgesia in rats - a time course study. Eur J Pharm 2003 464 : 159 62.
14. Tassorelli C, Greco R, Sandrini G, Nappi G. Central components of the analgesic/anti-hyperalgesic effect of nimesulide: studies in animal models of pain and hyperalgesia. Drugs 2003 63 : 9 22.
15. Tassorelli C, Joseph SA. Systemic nitroglycerin induces Fos-ir in brainstem and forebrain structures of the rat. Brain Res 1995 682 : 167 78.
16. Tassorelli C, Joseph SA, Nappi G. Central effects of nitroglycerin in the rat: new perspectives in migraine research. Funct Neurol 1996 11 : 219 23.
17. Tassorelli C, Joseph SA, Buzzi G, Nappi G. The effect on the central nervous system of nitroglycerin - putative mechanisms and mediators. Prog Neurobiol 1999 57 : 606 24.
18. Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, Maassen Van Den Brink A et al. Experimental models of migraine. Looking at the component parts of a complex disorder. Eur J Neurosci 2006 24 : 1517 34.
19. Tjolsen Aberge OG, Hunskaar S, Rosland JH, Hole K. The formalin test: an evaluation of the method. Pain 1992 51 : 5 17.
20. Humnskarr S, Fasmer OB, Hole K. Formalin test in mice, a useful technique for evaluating mild analgesics. J Neurosci Methods 1985 14 : 69 76.
21. Nahin RL, Hylden JLK, Hunphrey E. Demonstration of dynorphin1-8 immunoreactive axons contacting spinal cord projection neurons in a rat model of peripheral inflammation and hyperalgesia. Pain 1992 51 : 134 43.
22. McCarson KE, Goldstein BD. Time course of the alteration in dorsal horn substance P levels following formalin: blockade by naloxone. Pain 1990 41 : 95 100.
23. Tassorelli C, Greco R, Morazzoni P, Riva A, Sandrini G, Nappi G. Parthenolide is the component of tanacetum parthenium that inhibits nitroglycerin-induced Fos activation: studies in an animal model of migraine. Cephalalgia 2005 25 : 612 21.
24. Tassorelli C, Greco R, Cappelletti D, Sandrini G, Nappi G. Comparative analysis of the neuronal activation and cardiovascular effects of nitroglycerin, sodium nitroprusside and L-arginine. Brain Res 2005 1051 : 17 24.
25. Jones MG, Lever I, Bingham S, Read S, McMahon SB, Parsons A. Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat. Cephalalgia 2001 21 : 643 55.
26. Martin RS, Martin GR. Investigations into migraine pathogenesis: time course for effects of m-CPP, BW723C86 or glyceryl trinitrate on appearance of Fos-like immunoreactivity in rat trigeminal nucleus caudalis (TNC). Cephalalgia 2001 21 : 46 52.
27. Johnson EM, Bullitt E. Computer programs for the analysis of immunohistochemically labeled spinal cord sections. J Neurosci Methods 1990 31 : 119 32.
28. Wang X, Marvizon JC. Time-course of the internalization and recycling of neurokinin 1 receptors in rat dorsal horn neurons. Brain Res 2000 944 : 239 47.
29. Trang T, Sutak M, Quirion R, Jhamandas K. The role of spinal neuropeptides and prostaglandins in opioid physical dependence. Br J Pharmacol 2002 136 : 37 8.
30. Bailey AL, Riberiro-Da-Silva A. Transient loss of terminals from non-peptidergic nociceptive fibres in the substantia gelatinosa of spinal cord following chronic constriction injury of the sciatic nerve. Neuroscience 2006 138 : 675 90.
31. Pardutz A, Multon S, Malgrange B, Parducz A, Vecsei L, Schoenen J. Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen. Eur J Neurosci 2002 15 : 1803 9.
32. Wei EP, Moskowitz MA, Boccalini P, Kontos HA. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992 70 : 1313 19.
33. Ghatta S, O'Rourke ST. Nitroglycerin-induced release of calcitonin gene-related peptide from sensory nerves attenuates the development of nitrate tolerance. J Cardiovasc Pharmacol 2006 47 : 175 81.
34. Bellamy J, Bowen E, Russo AF, Durham PL. Nitric oxide regulation of calcitonin gene-related peptide gene expression in rat trigeminal ganglia neurons. Eur J Neurosci 2006 23 : 2057 66.
35. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003 106 : 461 70.
36. Lambert GA, Donaldson C, Boers PM, Zagami AS. Activation of trigeminovascular neurons by glycerol trinitrate. Brain Res 2000 887 : 253 9.
37. Pardutz A, Krizbai I, Multon S, Vecsei L, Schoenen J. Systemic nitroglycerin increases nNOS levels in rat trigeminal nucleus caudalis. Neuroreport 2000 11 : 3071 5.
38. Torfgard K, Ahnler J, Axelsson KL, Norlander B, Bertler A. Tissue levels of glyceryl trinitrate and cGMP after in vivo administration in rat, and the effect on tolerance development. Can J Physiol Pharmacol 1991 169 : 1257 61.
39. Zhou ZH, Deng HW, Li YJ. The depressor effect of nitroglycerin is mediated by calcitonin gene-related peptide. Life Sci 2001 69 : 1313 20.
40. Tassorelli C, Blandini F, Greco R, Nappi G. Nitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brain. J Chem Neuroanat 2004 27 : 23 32.
41. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988 24 : 739 68.
42. Geppetti P, Capone JG, Trevisani M, Nicoletti P, Zagli G, Tola MR. CGRP and migraine: neurogenic inflammation revisited. J Headache Pain 2005 6 : 61 70.
43. Buzzi MG, Moskowitz MA. The pathophysiology of migraine: year 2005. Pain 2005 6 : 105 11.
44. Knyihar-Csillik E, Tajti J, Samsam M, Sáry G, Buzás P, Vécsei L. Depletion of calcitonin gene-related peptide from the caudal trigeminal nucleus of the rat after electrical stimulation of the Gasserian ganglion. Exp Brain Res 1998 118 : 111 4.
45. Samsam M, Covenas R, Ahangari R, Yajeya J, Narvaez JA, Tramu G. Alterations in neurokinin A-, substance P- and calcitonin gene-related peptide immunoreactivities in the caudal trigeminal nucleus of the rat following electrical stimulation of the trigeminal ganglion. Neurosci Lett 1999 261 : 179 8.
46. Kantner RM, Goldstein BD, Kirby ML. Regulatory mechanisms for substance P in the dorsal horn during a nociceptive stimulus: axoplasmic transport vs electrical activity. Brain Res 1986 385 : 282 90.
47. Zhang RX, Mi ZP, Qiao JT. Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 1994 51 : 25 32.
48. Marvizon JCG, Wang X, Matsuka Y, Neubert JK, Spigelman I. Relationship between capsaicin-evoked substance P release and neurokinin 1 receptor internalisation in the rat spinal cord. Neuroscience 2003 118 : 535 45.
49. Bennett VJ, Perrine SA, Simmons MA. Neurokinin-1 receptor resensitization precedes receptor recycling. J Pharmacol Exp Ther 2005 313 : 1347 54.
50. Ma QP, Hill R, Sirinathsinghji D. Colocalization of CGRP with 5-HT1B/1D receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001 13 : 2099 104.
51. Gulbenkian S, Uddman R, Edvinsson L. Neuronal messengers in the human cerebral circulation. Peptides 2001 22 : 995 1007.
52. Iversen HK, Olesen J. Headache induced by a nitric oxide donor (nitroglycerin) responds to sumatriptan. A human model for development of migraine drugs. Cephalalgia 1996 16 : 412 18.
53. Goldstein DJ, Wang O, Saper JR, Stoltz R, Silberstein SD, Mathew NT. Ineffectiveness of neurokinin-1 antagonist in acute migraine: crossover study. Cephalalgia 1997 17 : 785 90.
54. Fanciullacci M, Alessandri M, Geppetti P, Michelacci S. Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack. Pain 1995 60 : 119 22.
55. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U et al.; BIBN 4096 BS Clinical Proof of Concept Study Group. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004 11 : 1104 10.
56. Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J et al. NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 2003 106 : 461 7.
57. Goadsby PJ, Edvinsson L. The trigeminal-vascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993 33 : 48 56.
58. Knyihar-Csillik E, Toldi J, Mihaly A, Krisztin-Peva B, Chadaide Z, Nemeth H et al. Kynurenine in combination with probenecid mitigates the stimulation-induced increase of c-fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine model. J Neural Transm 2007 114 : 417 21.
59. Aimar P, Pasti L, Carmignoto G, Merighi A. Nitric oxide-producing islet cells modulate the release of sensory neuropeptides in the rat substantia gelatinosa. J Neurosci 1998 18 : 10375 88.
60. Kamisaki Y, Nakamoto K, Wada K, Itoh T. Nitric oxide regulates substance P release from rat spinal cord synaptosomes. J Neurochem 1995 65 : 2050 6.
61. Duggan AW, Morton CR, Zhao ZQ, Hendry IA. Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: a study with antibody microprobes. Brain Res 1987 325 : 294 8.
62. Morton CR, Hutchison WD. Release of sensory neuropeptides in the spinal cord: studies with calcitonin gene-related peptide and galanin. Neuroscience 1989 31 : 807 15.
63. Zhang RX, Mi Z, Qiao JT. Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 1994 51 : 25 32.
64. Holland LN, Goldestein BD. Changes of substance P-like immunoreactivity in the dorsal horn are associated with the phasic behavioural response to a formalin stimulus. Brain Res 1990 537 : 287 92.
65. Calcutt NA, Stiller C, Gustafsson H, Malmberg AB. Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats. Brain Res 2000 856 : 20 7.
66. Honor P, Menning PM, Rogers SD, Nichols ML, Basbaum AI, Besson JM et al. Spinal substance P receptor expression and internalization in acute, short-term, and long-term inflammatory pain states. J Neurosci 1999 19 : 7670 8.
67. Holland LN, Goldstein BD. Examination of tonic nociceptive behavior using a method of substance P-receptor desensitization in the dorsal horn. Pain 1994 56 : 339 46.
68. Tsuruoka M, Maeda M, Inoue T. Persistent hindpaw inflammation produces coeruleospinal antinociception in the non-inflamed forepaw of rats. Neurosci Lett 2004 367 : 66 70.